Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
Market
Cytokinetics, Incorporated
Buy
Sell
One time
USD
CYTK
≈
0.12523482
CYTK
$50
$150
$500
Pay with
Google Pay
Apple Pay
USD Account
1-2 business days • No fees
Credit/debit card
Instant •
2.99%
0% fee first 30 days
| Time | Price | Change |
|---|---|---|
| Today | 0.00% | |
| 1 day | -$0.20 (1.45%) | |
| 1 week | -$1.26 (2.02%) | |
| 1 month | -$2.34 (3.29%) | |
| 1 year | +$2.90 (4.77%) |
CYTK
$79.85
-1.45%
Rank
#12714
All-time high
$90.00
-12.71%
All-time low
$66.21
17.08%
Cytokinetics is a biopharmaceutical company focused on cancer and cardiovascular disease treatment. Co.'s drug candidate, SB-715992, is a Phase II clinical trials program conducted by its partner GlaxoSmithKline and the National Cancer Institute.
Make investing stress-free
Trade with deep liquidity and low fees
